Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Mayne Pharma (ASX:MYX): Share Price Movement, Women’s Health Expansion and Business Strategy Explained

Mayne Pharma Group (ASX:MYX) shares closed at AUD 3.35, up 3.72% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s specialty pharmaceutical portfolio, Women’s Health growth strategy and operational transition.

Aditi Sarkar | 20 August 2026

Oceania Healthcare (ASX:OCA) Under Spotlight as Investors Assess Record Sales and Debt Reduction

Oceania Healthcare Limited (ASX:OCA) shares closed at AUD 0.67, up 0.75% on 20 August 2026. The movement reflects a slightly positiveTrading sessionas investors continue to assess the company’s retirement village platform, aged care operations and ongoingBusinessreset.

Aditi Sarkar | 20 August 2026

Racura Oncology (ASX:RAC): RC220 Clinical Pipeline Progress Drives Investor Attention

Racura Oncology Limited (ASX:RAC) shares closed at AUD 2.10, down 0.94% on 20 August 2026. The movement reflects a slightly weakerTrading sessionas investors continue to assess the company’s oncology development programs, clinical milestones and funding position.

Aditi Sarkar | 20 August 2026

AFT Pharmaceuticals (ASX:AFP): Revenue Growth, Licensing Momentum and R&D Investment in Focus

AFT Pharmaceuticals (ASX:AFP) shares closed at AUD 3.60, down 5.26% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s pharmaceutical portfolio, international growth strategy andInvestmentinto future product opportunities.

Aditi Sarkar | 20 August 2026

Starpharma (ASX:SPL) Gains Momentum as Investors Track Clinical Preparation and Partnerships

Starpharma Holdings (ASX:SPL) shares closed at AUD 0.76, up 4.83% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s dendrimer technology platform, oncology pipeline and partnership strategy.

Aditi Sarkar | 20 August 2026

Healius (ASX:HLS): Pathology Recovery, AI Adoption and Cost Reset Shape the Next Growth Phase

Healius Limited (ASX:HLS) shares closed at AUD 0.465, up 10.71% on 20 August 2026. The movement reflects a strongerTrading sessionas investors assessed the company’s FY26 performance, pathologyMarginimprovement and ongoing transformation initiatives.

Aditi Sarkar | 20 August 2026

Monash IVF Group (ASX:MVF) Edges Higher Amid Positive Healthcare Sector Momentum

Monash IVF Group (ASX:MVF) shares closed at AUD 0.725, up 0.69% on 20 August 2026. The movement reflects a slightly positiveTrading sessionas investors continue to assess the company’s fertility services platform, patientDemandtrends and operational performance.

Aditi Sarkar | 20 August 2026

Pacific Edge (ASX:PEB) Under Review as Investors Track Reimbursement Milestones and Clinical Adoption

Pacific Edge Limited (ASX:PEB) shares closed at AUD 0.21, down 4.55% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s bladder cancer diagnostics platform, Medicare reimbursement pathway and commercial recovery strategy.

Aditi Sarkar | 20 August 2026

Vitrafy Life Sciences (ASX:VFY): US Expansion, FDA Pathway and Commercial Partnerships in Focus

Vitrafy Life Sciences (ASX:VFY) shares closed at AUD 4.10, down 5.31% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s transition from technology development towards commercial deployment.

Aditi Sarkar | 20 August 2026

AVITA Medical (ASX:AVH) Shares Rise 4.06% as Commercial Momentum Builds

AVITA Medical (ASX:AVH) shares closed at AUD 2.82, up 4.06% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s acute wound care portfolio, commercial execution and pathway towards cash flow breakeven.

Aditi Sarkar | 20 August 2026
Support

Hi! How can we help you today?

Loading…